Moberg Pharma AB (publ) (STO:MOB)
9.33
-0.04 (-0.43%)
Jul 24, 2026, 5:19 PM CET
Moberg Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 230.95 | 293.29 | 60.56 | 125.55 | 102.66 |
Cash & Short-Term Investments | 230.95 | 293.29 | 60.56 | 125.55 | 102.66 |
Cash Growth | -21.25% | 384.33% | -51.77% | 22.30% | -21.65% |
Accounts Receivable | 2.33 | 0.17 | - | 0.38 | 0.47 |
Other Receivables | 0.37 | 0.64 | 0.79 | 1.06 | 0.66 |
Total Trade Receivables | 2.7 | 0.8 | 0.79 | 1.44 | 1.14 |
Inventory | 3.58 | 4.3 | 7.12 | - | - |
Other Current Assets | 0.69 | 1.73 | 1.04 | 0.77 | 0.86 |
Total Current Assets | 237.91 | 300.11 | 69.49 | 127.76 | 104.66 |
Net Property, Plant & Equipment | 2.81 | 4.42 | 4.94 | 5.98 | 4.52 |
Other Intangible Assets | - | - | 532.22 | 408.1 | 327.04 |
Other Long-Term Assets | 92.58 | 95.78 | 28.08 | 22.58 | 14.67 |
Total Assets | 682.26 | 706.09 | 634.73 | 564.42 | 450.89 |
Accounts Payable | 2.93 | 4.16 | 6.77 | 17.11 | 5.31 |
Accrued Expenses | 9.42 | 8.98 | 9.23 | 6.54 | 6.57 |
Current Portion of Leases | 1.68 | 1.6 | 1.27 | 2.12 | 2.7 |
Other Current Liabilities | 2.15 | 1.98 | 3.27 | 1.02 | 0.97 |
Total Current Liabilities | 16.17 | 16.72 | 20.54 | 26.79 | 15.54 |
Long-Term Leases | 0.87 | 2.55 | 3.47 | 3.99 | 1.24 |
Other Long-Term Liabilities | - | - | - | 0.07 | 0.07 |
Total Long-Term Liabilities | 0.87 | 2.55 | 3.47 | 4.05 | 1.3 |
Total Liabilities | 17.04 | 19.27 | 24.01 | 30.84 | 16.84 |
Common Stock | 47 | 46.69 | 27.96 | 9.83 | 4.41 |
Additional Paid-in Capital | 1,239 | 1,234 | 921.3 | 841.2 | 731.38 |
Retained Earnings | -620.88 | -593.64 | -338.53 | -317.44 | -301.73 |
Total Common Shareholders' Equity | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 |
Shareholders' Equity | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 |
Total Liabilities & Equity | 682.26 | 706.09 | 634.73 | 564.42 | 450.89 |
Total Debt | 2.55 | 4.14 | 4.74 | 6.11 | 3.93 |
Net Cash (Debt) | 228.4 | 289.15 | 55.82 | 119.45 | 98.72 |
Net Cash Growth | -21.01% | 418.02% | -53.27% | 20.99% | -20.14% |
Net Cash Per Share | 4.74 | 7.43 | 1.57 | 15.41 | 22.37 |
Book Value | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 |
Book Value Per Share | 13.80 | 17.65 | 17.19 | 68.83 | 98.35 |
Tangible Book Value | 665.22 | 686.82 | 78.51 | 125.48 | 107.01 |
Tangible Book Value Per Share | 13.80 | 17.65 | 2.21 | 16.19 | 24.25 |